Edwin Dejesus


AuthID: R-00F-KK6

Publicações a aguardar confirmação

1
TÍTULO: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results
AUTORES: Joel E Gallant; Ellen Koenig; Jaime F Andrade Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes; Keikawus Arasteh; Giuliano Rizzardini; Jan Fehr; Hui C Liu; Michael E Abram; Huyen Y Cao; Javier Szwarcberg;
PUBLICAÇÃO: 2015, FONTE: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 69, NÚMERO: 3
INDEXADO EM: Scopus WOS
2
TÍTULO: Brief Report. Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate
AUTORES: Joel E Gallant; Ellen Koenig; Jaime F Andrade-Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes; Keikawus Arastéh; Giuliano Rizzardini; Jan Fehr; Hui C Liu; Michael E Abram; Huyen Cao; Javier Szwarcberg;
PUBLICAÇÃO: 2015, FONTE: JAIDS Journal of Acquired Immune Deficiency Syndromes, VOLUME: 69, NÚMERO: 3
INDEXADO EM: CrossRef
3
TÍTULO: Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
AUTORES: Castagna, A; Maggiolo, F; Penco, G; Wright, D; Mills, A; Grossberg, R; J.-M Molina; Chas, J; Durant, J; Moreno, S; Doroana, M; Ait-Khaled, M; Huang, J; Min, S; Song, I; Vavro, C; Nichols, G; Yeo, JM; Aberg, J; Akil, B; Arribas, JR; J.- G Baril; Blanco Arevalo, JL; Blanco Quintana, F; Blick, G; Boix Martinez, V; Bouchaud, O; Branco, T; Bredeek, UF; Castro Iglesias, M; Clumeck, N; Conway, B; DeJesus, E; J.- L Delassus; De Truchis, P; Di Perri, G; Di Pietro, M; Duggan, J; Duvivier, C; Elion, R; Eron, J; Fish, D; Gathe, J; Haubrich, R; Henderson, H; Hicks, C; Hocqueloux, L; Hodder, S; C.- B Hsiao; Katlama, C; Kozal, M; Kumar, P; Lalla-Reddy, S; Lazzarin, A; Leoncini, F; Llibre, JM; Mansinho, K; Morlat, P; Mounzer, K; Murphy, M; Newman, C; Nguyen, T; Nseir, B; Philibert, P; Pialoux, G; Poizot-Martin, I; Ramgopal, M; Richmond, G; Salmon Ceron, D; Sax, P; Scarsella, A; Sension, M; Shalit, P; Sighinolfi, L; Sloan, L; Small, C; Stein, D; Tashima, K; Tebas, P; Torti, C; Tribble, M; Troisvallets, D; Tsoukas, C; Viciana Fernandez, P; Ward, D; Wheeler, D; Wilkin, T; G.- P Yeni; Louise Martin-Carpenter, J; Uhlenbrauck, G; ...Mais
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 210, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef
4
TÍTULO: Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results
AUTORES: Joel E Gallant; Ellen Koenig; Jaime Andrade Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes ; Keikawus Arasteh; Graeme Moyle; Giuliano Rizzardini; Jan Fehr; Yapei P Liu; Lijie J Zhong; Christian Callebaut; Javier Szwarcberg; Martin S Rhee; Andrew K Cheng;
PUBLICAÇÃO: 2013, FONTE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 208, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef
5
TÍTULO: Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults  Full Text
AUTORES: DeJesus, E; Herrera, G; Teofilo, E; Gerstoft, J; Buendia, CB; Brand, JD; Brothers, CH; Hernandez, J; Castillo, SA; Bonny, T; Lanier, ER; Scott, TR;
PUBLICAÇÃO: 2004, FONTE: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy in CLINICAL INFECTIOUS DISEASES, VOLUME: 39, NÚMERO: 7
INDEXADO EM: Scopus WOS CrossRef

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service